In December, the U.S.-based National Academy of Sciences published a report classifying myopia, for the first time, as a ...

Myopes may undergo about –1 D of progression between the ages of 20 and 50 years, according to an analysis of three large ...

What started as a scholarly study becomes, in Will Rees’s hands, a freewheeling journey into our brains and souls.

The FDA accepted a new drug application for SYD-101 to slow the progression of pediatric myopia and assigned a Prescription ...

Paediatric ophthalmologist, Dr Katie Williams, discusses her research exploring factors associated with myopia ...

Sydnexis, Inc. ( a pre-commercial stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration ...

High levels of exposure to air pollution can increase the incidence of diabetic retinopathy and glaucoma, a recent study ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of ...

The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.

An analysis of data from more than 100 studies and 17,000 children has questioned the effectiveness of myopia management ...

Excessive screen time for more than 4 hours per day may significantly increase the risk of developing myopia Digital Screen Time and Myopia A Systematic Review and Dose-Response Meta-Analysis - (https ...

Brianna Rhue, OD, FAAO, discussed novel approaches to myopia management and how they can be implemented into clinical ...